Dyslipidemia in patients taking anti-retroviral therapy
Year: 2014
Type: article
Study design: Observational Study
Abstract: Background: People with human immunodeficiency virus (HIV) infection are living longer with the use of anti-retroviral therapy (ART). But as they do, non-HIV medical problems become more relevant. In particular dyslipidemia, an important reversible risk factor for cardiovascular disease, has been linked to HIV infection and its treatment. Its pathogenesis is complex and includes factor related to the virus, the host and ART. Our aim is to study the changes in the lipid profile in the patients of HIV taking ART. Methods: Data were collected from 50 normotensive, non-diabetic and non-obese, HIV-infected patients who were on ART for at least 6 months at ART Center, Civil hospital, Ahmedabad, Gujarat and 50 healthy normal controls. Fasting lipid profiles were analyzed enzymatically by colorimetric method in fully automated Erba XL-640 Analyser. Results: The level of serum total cholesterol (TC), serum triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) were increase while high-density lipoprotein cholesterol (HDL-C) were decrease in patients of HIV who were on ART for at least 6 month as compared to the normal subjects (p value <0.05). Conclusion: The study has demonstrated dyslipidemia in HIV infected patients receiving ART. There is a need for monitoring lipid profile in patients on ART.
Institution: B.J. Medical College
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W1609034147